Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Immuno-inflammatory Disorders Therapies	41.10M	Log In	Log In
Immuno-inflammatory Disorders Therapies Growth	13.89%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	41.10M	Log In	Log In
United States Growth	13.89%	Log In	Log In